PWMG
WST icon

Private Wealth Management Group’s West Pharmaceutical WST Stock Holding History

Private Wealth Management Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15K Hold
6
– – ﹤0.01% 1143
2026
Q1 		$1.5K Hold
6
– – ﹤0.01% 1163
2025
Q4 		$1.65K Hold
6
– – ﹤0.01% 1148
2025
Q3 		$1.57K Hold
6
– – ﹤0.01% 1183
2025
Q2 		$1.31K Sell
6
-17
-74% -$3.63K ﹤0.01% 1197
2025
Q1 		$5.15K Buy
23
+21
+1,050% +$5.79K ﹤0.01% 717
2024
Q4 		$656 Hold
2
– – ﹤0.01% 1392
2024
Q3 		$601 Hold
2
– – ﹤0.01% 1398
2024
Q2 		$659 Hold
2
– – ﹤0.01% 1382
2024
Q1 		$792 Hold
2
– – ﹤0.01% 1342
2023
Q4 		$705 Buy
+2
New +$708 ﹤0.01% 1383

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Private Wealth Management Group's WST Position: Q2 2026 in Review

Private Wealth Management Group held its West Pharmaceutical (WST) position steady in Q2 2026 at 6 shares worth $2.15K. The position accounts for ﹤0.01% of the portfolio, ranked #1143.

Private Wealth Management Group first reported a position in WST in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.15K in Q1 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Private Wealth Management Group held 6 shares of West Pharmaceutical worth $2.15K as of Q2 2026.
  • Private Wealth Management Group left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #1143 holding.
  • Private Wealth Management Group first reported a position in West Pharmaceutical in Q4 2023 and has held it in 11 quarters since.
  • Private Wealth Management Group's West Pharmaceutical position peaked at $5.15K in Q1 2025.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.